<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>My Documentation</title>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/marked/9.1.6/marked.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-core.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/plugins/autoloader/prism-autoloader.min.js"></script>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism-tomorrow.min.css" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.7;
            color: #24292f;
            background: #ffffff;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            padding: 3rem 2rem;
        }

        .content h1 {
            font-size: 2.5rem;
            font-weight: 700;
            color: #1a1a1a;
            margin: 0 0 2rem 0;
            border-bottom: 3px solid #0969da;
            padding-bottom: 0.5rem;
        }

        .content h2 {
            font-size: 2rem;
            font-weight: 600;
            color: #1a1a1a;
            margin: 3rem 0 1.5rem 0;
            border-bottom: 1px solid #d1d9e0;
            padding-bottom: 0.5rem;
        }

        .content h3 {
            font-size: 1.5rem;
            font-weight: 600;
            color: #1a1a1a;
            margin: 2.5rem 0 1rem 0;
        }

        .content h4 {
            font-size: 1.25rem;
            font-weight: 600;
            color: #1a1a1a;
            margin: 2rem 0 1rem 0;
        }

        .content h5, .content h6 {
            font-size: 1rem;
            font-weight: 600;
            color: #1a1a1a;
            margin: 1.5rem 0 1rem 0;
        }

        .content p {
            margin-bottom: 1.5rem;
            font-size: 1rem;
            line-height: 1.7;
            color: #24292f;
        }

        .content a {
            color: #0969da;
            text-decoration: none;
            font-weight: 500;
        }

        .content a:hover {
            text-decoration: underline;
        }

        .content strong {
            font-weight: 700;
            color: #1a1a1a;
        }

        .content em {
            font-style: italic;
        }

        .content code {
            background: #f6f8fa;
            padding: 0.2rem 0.4rem;
            border-radius: 6px;
            font-size: 0.85rem;
            font-family: 'SF Mono', Monaco, 'Cascadia Code', 'Roboto Mono', Consolas, monospace;
            color: #24292f;
            border: 1px solid #d1d9e0;
        }

        .content pre {
            background: #0d1117;
            border-radius: 12px;
            padding: 1.5rem;
            margin: 2rem 0;
            overflow-x: auto;
            border: 1px solid #30363d;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.1);
        }

        .content pre code {
            background: none;
            padding: 0;
            border: none;
            color: inherit;
            font-size: 0.9rem;
        }

        .content blockquote {
            border-left: 4px solid #0969da;
            padding: 1rem 1.5rem;
            margin: 2rem 0;
            background: #f6f8fa;
            border-radius: 0 8px 8px 0;
            color: #656d76;
        }

        .content blockquote p {
            margin-bottom: 0;
        }

        .content ul, .content ol {
            margin: 1.5rem 0;
            padding-left: 2rem;
        }

        .content li {
            margin-bottom: 0.5rem;
            line-height: 1.7;
        }

        .content li p {
            margin-bottom: 0.5rem;
        }

        .content table {
            width: 100%;
            border-collapse: collapse;
            margin: 2rem 0;
            font-size: 0.9rem;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
            border-radius: 8px;
            overflow: hidden;
        }

        .content th {
            background: #f6f8fa;
            padding: 12px 16px;
            text-align: left;
            font-weight: 600;
            color: #24292f;
            border-bottom: 2px solid #d1d9e0;
        }

        .content td {
            padding: 12px 16px;
            border-bottom: 1px solid #d1d9e0;
            color: #24292f;
        }

        .content tr:last-child td {
            border-bottom: none;
        }

        .content tr:nth-child(even) {
            background: #f8f9fa;
        }

        .content hr {
            border: none;
            height: 2px;
            background: linear-gradient(90deg, #d1d9e0, transparent);
            margin: 3rem 0;
        }

        .content img {
            max-width: 100%;
            height: auto;
            border-radius: 8px;
            margin: 1.5rem 0;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.1);
        }

        /* Task lists */
        .content input[type="checkbox"] {
            margin-right: 0.5rem;
        }

        .content li.task-list-item {
            list-style: none;
            margin-left: -2rem;
            padding-left: 2rem;
        }

        /* Responsive design */
        @media (max-width: 768px) {
            .container {
                padding: 2rem 1rem;
            }
            
            .content h1 {
                font-size: 2rem;
            }
            
            .content h2 {
                font-size: 1.5rem;
            }
            
            .content h3 {
                font-size: 1.25rem;
            }
            
            .content pre {
                padding: 1rem;
                margin: 1.5rem -1rem;
                border-radius: 0;
            }
            
            .content table {
                font-size: 0.8rem;
            }
            
            .content th, .content td {
                padding: 8px 12px;
            }
        }

        /* Custom scrollbar */
        ::-webkit-scrollbar {
            width: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f3f4;
        }

        ::-webkit-scrollbar-thumb {
            background: #c1c8cd;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #a8b1b8;
        }

        /* Smooth scrolling */
        html {
            scroll-behavior: smooth;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="content" id="content">
            <!-- Your markdown content will be rendered here -->
        </div>
    </div>

    <script>
        // Configure marked options
        marked.setOptions({
            highlight: function(code, language) {
                if (Prism.languages[language]) {
                    return Prism.highlight(code, Prism.languages[language], language);
                }
                return code;
            },
            breaks: true,
            gfm: true
        });

        // Your markdown content goes here
        const markdownContent = `
# 1. Chronic Obstructive Pulmonary Disease (COPD)

**Disease Specifics:** COPD is a group of progressive lung diseases characterized by persistent airflow limitation and breathing difficulties. It consists primarily of two conditions:
- **Emphysema**: Destruction of the air sacs (alveoli) in the lungs, reducing the surface area for oxygen exchange and causing the lungs to lose their elasticity
- **Chronic bronchitis**: Long-term inflammation of the bronchial tubes with thickening of the tube walls and increased mucus production, obstructing airflow

COPD causes irreversible damage to lung tissue, leading to trapped air, reduced oxygen transfer to the bloodstream, and progressive shortness of breath.

**Global Impact:** As of 2019, COPD affected approximately 212 million people globally and was responsible for 3.3 million deaths, making it the leading cause of death among chronic respiratory diseases.

**Risk Factors:**
- Tobacco smoke (active and passive exposure)
- Air pollution
- Occupational exposure to dust and chemicals
- Genetic factors (e.g., alpha-1 antitrypsin deficiency)

**Prevention and Management:**
- Smoking cessation programs
- Reducing exposure to indoor and outdoor pollutants
- Regular medical check-ups for early detection
- Pulmonary rehabilitation and appropriate medications

---

# 2. Lower Respiratory Infections (LRIs)

**Disease Specifics:** Lower respiratory infections are acute infectious diseases that affect the airways below the larynx, including:
- **Pneumonia**: Infection of the lung air sacs (alveoli) causing them to fill with fluid or pus
- **Acute bronchitis**: Inflammation of the bronchial tubes with increased mucus production
- **Bronchiolitis**: Inflammation of the small airways (bronchioles), primarily affecting young children
- **Tracheitis**: Inflammation of the trachea (windpipe)

These infections can be bacterial (e.g., Streptococcus pneumoniae), viral (e.g., influenza, RSV), or fungal, and cause symptoms ranging from productive cough to severe respiratory distress.

**Global Impact:** In 2021, there were an estimated 344 million incident cases of LRIs, leading to approximately 2.18 million deaths worldwide.

**Risk Factors:**
- Weakened immune system
- Malnutrition
- Lack of access to clean water and sanitation
- Exposure to indoor air pollution

**Prevention and Management:**
- Vaccination (e.g., pneumococcal and influenza vaccines)
- Improved nutrition and sanitation
- Timely medical intervention with appropriate antibiotics or antivirals
- Public health education on hygiene practices

---

# 3. Lung Cancer

**Disease Specifics:** Lung cancer is a malignant tumor characterized by uncontrolled cell growth in lung tissues that can invade adjacent structures and metastasize to distant organs. It is classified into two main types:
- **Non-small cell lung cancer (NSCLC)**: Accounts for 85% of cases and includes:
  - Adenocarcinoma: Originates in the mucus-producing glandular cells of the lungs' outer regions
  - Squamous cell carcinoma: Develops in the flat cells lining the airways
  - Large cell carcinoma: Characterized by large, abnormal-looking cells that can appear anywhere in the lung
- **Small cell lung cancer (SCLC)**: More aggressive form that typically starts in the bronchi and spreads rapidly

Lung cancer disrupts normal lung function by creating masses that block airways, invade blood vessels, and destroy healthy tissue.

**Global Impact:** Lung cancer remains one of the most common and deadly cancers globally. In 2019, it was among the leading causes of cancer-related deaths.

**Risk Factors:**
- Tobacco smoking (primary risk factor)
- Exposure to radon gas
- Occupational exposure to carcinogens (e.g., asbestos)
- Air pollution

**Prevention and Management:**
- Smoking cessation and tobacco control policies
- Regular screenings for high-risk populations
- Early detection through imaging tests
- Treatment options including surgery, chemotherapy, and targeted therapies

---

# 4. Asthma

**Disease Specifics:** Asthma is a chronic inflammatory disorder of the airways characterized by:
- **Airway hyperresponsiveness**: Bronchial tubes overreact to various triggers
- **Bronchoconstriction**: Tightening of the smooth muscles surrounding the airways
- **Inflammation**: Swelling of the airway lining
- **Mucus hypersecretion**: Excessive production of thick mucus

During an asthma attack, these mechanisms cause narrowing of the airways, leading to wheezing, coughing, chest tightness, and shortness of breath. Unlike COPD, the airflow obstruction in asthma is usually reversible either spontaneously or with treatment.

**Global Impact:** Asthma affects over 262 million people worldwide and caused approximately 461,000 deaths in 2019.

**Risk Factors:**
- Genetic predisposition
- Exposure to allergens (e.g., pollen, dust mites)
- Air pollution
- Respiratory infections during childhood

**Prevention and Management:**
- Avoiding known triggers
- Regular use of prescribed inhalers
- Monitoring lung function
- Education on self-management techniques

---

# 5. Respiratory Syncytial Virus (RSV)

**Disease Specifics:** RSV is a single-stranded RNA virus of the Pneumoviridae family that specifically attacks the respiratory epithelium, causing:
- **Bronchiolitis**: Inflammation and congestion of the small airways (bronchioles)
- **Interstitial pneumonia**: Inflammation of the tissue between the air sacs of the lungs
- **Necrosis of epithelial cells**: Death of cells lining the respiratory tract
- **Syncytia formation**: Fusion of infected cells creating characteristic multinucleated giant cells

The virus destroys ciliated epithelial cells, impairing mucus clearance and causing airway obstruction with mucus and cellular debris. In severe cases, particularly in infants, this leads to respiratory distress with labored breathing, decreased oxygen levels, and potential respiratory failure.

**Global Impact:** RSV is a leading cause of lower respiratory tract infections in young children. In 2019, it was responsible for approximately 100,000 deaths among children under five years of age.

**Risk Factors:**
- Premature birth
- Chronic lung or heart disease
- Weakened immune system
- Exposure to tobacco smoke

**Prevention and Management:**
- Good hygiene practices (e.g., handwashing)
- Avoiding close contact with sick individuals
- Use of prophylactic medications for high-risk infants
- Supportive care, including oxygen therapy and hydration

---

# Conclusion:

These respiratory diseases collectively impose a significant burden on global health systems. Preventive measures, early diagnosis, and effective management strategies are crucial to reduce their impact. Public health initiatives focusing on vaccination, pollution control, and education can play a pivotal role in mitigating the risks associated with these diseases.
`;

        // Render the markdown
        function renderMarkdown() {
            const html = marked.parse(markdownContent);
            document.getElementById('content').innerHTML = html;
            
            // Highlight code blocks
            Prism.highlightAll();
        }

        // Render on page load
        document.addEventListener('DOMContentLoaded', renderMarkdown);
    </script>
</body>
</html>
